Fundz

Portal Biotechnologies Raises $5M in pre-seed funding led by Pear VC and with participation from Conscience VC and 10x Capital for continued development and commercialization of cell engineering platform technology.

PRIVATEMar 19, 2024

Amount Raised

$5 Million

Round Type

Pre-Seed

CambridgeBiotechnologyArtificial Intelligence

Investors

10x CapitalConscience VCPear VC

Description

Portal Biotechnologies, Inc. raised $5 million in pre-seed funding, led by Pear VC and with participation from Conscience VC and 10x Capital. The company intends to use the funds for continued development and commercialization of cell engineering platform technology across research and clinical applications.

Who else raised in Biotechnology and Artificial Intelligence around the same time

Companies in the same sectors as Portal that raised within 45 days of this round, from Fundz verified event records.

  • Ikerian raised $6.2M (Series A) on May 2, 2024.
  • Vitestro raised $22M (Funding Round) on April 30, 2024.
  • Infinitopes raised $17M (Seed) on April 30, 2024.
  • AI Medical Technology raised $1.3M (Seed) on April 29, 2024.
  • Klineo raised $2.2M (Seed) on April 29, 2024.
  • Yoneda Labs raised $4M (Seed) on April 26, 2024.

Who to call at Portal, and when

A new round usually means Portal is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Portal raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Portal, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Portal. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Portal

Location

Cambridge, Massachusetts, United States

About

Portal is a cell engineering platform company focused on enabling next generation cell engineering and cell analytics across research and clinical applications. We are implementing a simplified approach to intracellular delivery, focused on accelerating advances enabled by the new generation of RNA, gene editing, and AI-driven technologies. Portal’s initial product suite is based on a proprietary mechanical delivery system capable of delivering many different types of cargo to a broad range of cell types. The technology's ability to be used stand-alone or as an integrated component of third-party systems provides a significant opportunity to broadly impact the fields of biological research and cellular therapeutics

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Portal raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJulie, Chief of Staff hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Portal's next move

See what Strategic adds

Portal raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.